Filing Details
- Accession Number:
- 0001104659-22-100931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-16 18:44:59
- Reporting Period:
- 2022-09-14
- Accepted Time:
- 2022-09-16 18:44:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1829635 | Transcode Therapeutics Inc. | RNAZ | Pharmaceutical Preparations (2834) | 811065054 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1854161 | Michael Robert Dudley | C/O Transcode Therapeutics, Inc. 6 Liberty Square, #2382 Boston MA 02109 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-14 | 20,000 | $1.15 | 893,114 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.1761, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Billionaire Hedge Funds
